(Q48044922)
Statements
1 reference
Health-related quality of life impact in a randomised phase III study of the combination of dabrafenib and trametinib versus dabrafenib monotherapy in patients with BRAF V600 metastatic melanoma (English)
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Dirk Schadendorf
1 reference
Keith T Flaherty
1 reference
Antoni Ribas
1 reference
Jhangir G Irani
1 reference
Claus Garbe
1 reference
Celeste Lebbe
1 reference
Douglas J DeMarini
1 reference
Helen Gogas
1 reference
Mayur M Amonkar
1 reference
James Larkin
1 reference
Vanna Chiarion-Sileni
1 reference
Michael Millward
1 reference
Mario Mandalà
1 reference
Paul Nathan
1 reference
Michelle Casey
1 reference
Gursel Aktan
1 reference
17 March 2015
1 reference
51
1 reference
7
1 reference
833-840
1 reference
Identifiers
1 reference